Loading
Ovarian Cancer Diagnosis and Treatment / Viral Associated Cancers and Disorders / Polyomavirus and Related Diseases · Journal article
Journal of Immunology and Clinical Microbiology · August 18, 2026
Early or partial results. Treat as a signal, not a conclusion.
This is a narrative review synthesizing observational epidemiological and laboratory data on the potential association between HIV infection and ovarian cancer development in women. The authors conclude that the relationship remains incompletely understood, with evidence limited, heterogeneous, and largely observational, suggesting possible contributing mechanisms (chronic inflammation, immune suppression, antiretroviral therapy) but no definitive causal or quantified risk estimates.
Narrative review. Women living with HIV, with focus on ovarian cancer risk.
Association between HIV and ovarian cancer remains incompletely understood Available evidence is limited, heterogeneous, and largely observational Possible contributing factors include chronic inflammation, immune suppression, and long-term antiretroviral drug use
Safety was not reported in the material analysed. Check the source before drawing any conclusion about harm.
This review identifies ovarian cancer as an underexplored issue in HIV-positive women and highlights the need for greater clinical awareness and targeted research; however, it does not provide quantified risk estimates or evidence-based clinical management recommendations, so its immediate utility for individual patient decision-making is limited.
A narrative review synthesizing heterogeneous observational studies with acknowledged limited and incompletely understood evidence; raises questions about HIV–ovarian cancer association rather than establishing a definitive answer.
As stated by the source record.
This review identifies ovarian cancer as an underexplored issue in HIV-positive women and highlights the need for greater clinical awareness and targeted research; however, it does not provide quantified risk estimates or evidence-based clinical management recommendations, so its immediate utility for individual patient decision-making is limited.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
What is missing. This record has no reported figures. That is a gap in the analysis, not a judgement about the study.
The growing concern over the intersection of ovarian cancer [OC] and Human Immunodeficiency Virus [HIV] among women has prompted considerable scientific inquiry into the possible implications of HIV for the incidence of ovarian malignancies. This review explores the occurrence of OC in HIV-positive women, examining the multifaceted pathophysiological interactions that may contribute to ovarian tumorigenesis in this population. The primary aim of the research is to evaluate the possible association between HIV infection and OC development, with a focus on immune dysfunction, viral load, and antiretroviral therapy as potential contributors. This review synthesizes findings from epidemiological studies, clinical trials, and laboratory investigations to highlight the complex interplay of immunosuppression and cancerogenesis in the context of HIV infection. The significance of this work lies in its potential to inform targeted healthcare strategies and interventions for HIV-positive women, addressing both cancer prevention and management in this vulnerable group. Methodologically, this review assesses the results of a comprehensive analysis of cross-sectional studies, cohort data, and case-control studies to evaluate the relationship between HIV and OC risk. The findings suggest that the association between HIV and OC remains incompletely understood, as the available evidence is limited, heterogeneous, and largely observational; possible contributing factors may include chronic inflammation, immune suppression, and long-term antiretroviral drug use. These findings contribute to a deeper understanding of the intersection of viral infections and cancer risk, with important implications for future research and public health policy. The practical significance of this research lies in its potential to support clinical awareness and improve recognition of this underexplored issue in HIV-positive women.
Taken from the source record, never inferred. Follow any of these and new work involving them reaches your briefing.